Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Gastroenterology | Infections and Infectious Diseases | Family Medicine
Disease Category: Inflammatory Bowel Disease
Location: United States, NY

Trial Information

Inflammatory Bowel Disease Exacerbation and Changes in Gut Microbiome and Innate Immunity

The researchers at the Rockefeller University Hospitals are doing this research to understand how microbes (tiny organisms, bacteria) that are found in the stool and lining (mucosal membrane) of the lower part of the colon is different in individuals with stable and not stable inflammatory bowel disease (IBD) compared to healthy individuals.

IBD is a name given to a group of medical problems in which the lining of the intestines become red and swollen causing abdominal (stomach) pain and cramping, loose frequent stool (diarrhea), weight loss and loss of appetite. Two of the most common types of IBD are ulcerative colitis (UC) and Crohn’s disease. For this study, subjects with the UC form of IBD will be enrolled. The symptoms of UC can wax and wane (get worse and get better) in the intensity and severity of illness. When there is severe inflammation, the disease is considered to be in an "active stage", and the person experiences a flare-up of the condition. When the degree of inflammation is less (or absent), the person usually is without symptoms, and the disease is considered to be in "remission". Our study is designed to examine the natural setting of the microbes in your lower intestines (gut) and how they act in people with IBD in active stage disease, in those whose IBD is in remission and in healthy volunteers.

About 50 people will take part in the research study at the Rockefeller University Hospital. Participation is about 13 months long and includes:

  • 1 to 2 sigmoidoscopies
  • Providing monthly stool samples for 12 months

The research study as a whole will last about 2 years.

Patient Inclusion Criteria:

  • Ages 18-65
  • Confirmed diagnosis of Ulcerative Colitis

Patient Exclusion Criteria:

  • IBD is currently in remission
  • HIV positive
  • Pregnant
  • History of a bleeding disorder

Clinical Research Support Office
The Rockefeller University Hospital
1230 York Avenue
New York, NY 10065
Phone: 1-800-RUCARES
Email: RUCARES@Rockefeller.edu

View Map

Research Center Information: The Rockefeller University Hospital

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.